UPS
53
2
FRT
43
5
HUM
31
-3
ADI
59
2
ZION
60
-3
BEN
45
-4
GOOG
83
-4
IPG
47
-2
KO
46
4
NI
65
-2
AON
32
-2
DE
53
-3
FOXA
63
6
SJM
23
2
DRI
45
-3
MAC
65
-2
XYL
35
-6
PH
64
-2
VLO
32
-3
EQR
44
4
UPS
53
2
FRT
43
5
HUM
31
-3
ADI
59
2
ZION
60
-3
BEN
45
-4
GOOG
83
-4
IPG
47
-2
KO
46
4
NI
65
-2
AON
32
-2
DE
53
-3
FOXA
63
6
SJM
23
2
DRI
45
-3
MAC
65
-2
XYL
35
-6
PH
64
-2
VLO
32
-3
EQR
44
4
Financhill
Back

Genus PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
16

GENSF
Genus PLC

Last Price:
21.01
Seasonality Move:
0.66%
Sell
37

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.59
Seasonality Move:
29.88%
Sell
16
Genus PLC (GENSF) is a Sell

Is Genus PLC a Buy, Sell or Hold?

  • The current Genus PLC [GENSF] share price is $21.01. The Score for GENSF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • GENSF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.63. The Score for ADAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GENSF Stock Price Chart

What is Genus PLC's stock price today?

  • The Genus PLC share price today is $21.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GENSF is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.

GENSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 19.86 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.47 - 23.29) Sell
Bollinger Bands (100): (21.34 - 24.08) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.35 Sell
Chaikin Money Flow: 411575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.62 - 0.76) Sell
Bollinger Bands (100): (0.73 - 1.15) Sell

GENSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.93 Buy
20-day SMA: 21.33 Sell
50-day SMA: 22.98 Sell
200-day SMA: 23.99 Sell
8-day EMA: 20.98 Buy
20-day EMA: 21.47 Sell
50-day EMA: 22.35 Sell
200-day EMA: 24.26 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.76 Sell
200-day SMA: 1.07 Sell
8-day EMA: 0.65 Sell
20-day EMA: 0.68 Sell
50-day EMA: 0.76 Sell
200-day EMA: 0.96 Sell

Genus PLC Earnings Growth & GENSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

Genus PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):